$IQV

STAUB W RICHARD sold $1.3M of IQV

STAUB W RICHARD (See Remarks) sold 5,500 shares of IQVIA HOLDINGS INC. (IQV) at $232.68 ($1.28M total) on 2026-08-03.

Original reporting
SEC EDGAR · STAUB W RICHARD
Published Aug 4, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 4, 2026, 9:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IQV
Neutral
medium confidence
Mentioned
$IQV
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IQVNeutralLow
01

Why it matters

The only new fact is the reported open-market sale size, price, and post-transaction holdings; it does not include any company-specific operational or financial update.

02

Market read

Traders may note the insider sale for sentiment, but there is no fundamental catalyst in the filing.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs, and the filing does not indicate any change in IQVIA’s outlook.

Relevance 6/10Novelty 3/10Timing: filed 2026-08-04 after-hours; sale executed 2026-08-03

Background

The article is an SEC Form 4 insider transaction disclosure for IQVIA Holdings Inc.

Company-level read

Ticker impact

$IQVNeutralMedium confidence
Context

IQVIA Form 4 shows officer Richard Staub sold 5,500 shares at $232.68 on 2026-08-03 for about $1.28M.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-only and typically fades.

Evidence & confidence

The filing is a primary-source Form 4, but it provides no earnings, guidance, deal, or regulatory catalyst. Insider sales are common and often not predictive without additional context.

Market effects

No clear sector read-through from a single insider sale at IQVIA.

None indicated.

None indicated.

Counterpoint

The absence of a 10b5-1 plan could be interpreted by some traders as less routine, potentially adding short-term skepticism.

Key entities

  • IQVIA Holdings Inc.

    Subject of the Form 4 insider transaction disclosure.

  • STAUB W RICHARD

    Officer who sold 5,500 shares of IQVIA on 2026-08-03.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IQVHighAI 8/10

IQVIA Holdings (IQV) Prices $2b In Senior Notes, Is The Stock Still Undervalued?

IQVIA Holdings (IQV) priced a $2b senior notes offering due 2034. The company's share price has surged 58.8% in 90 days, with a 1-year return of 42.3%. Analysts estimate a fair value of $275.17, suggesting a modest undervaluation. However, risks include contract pricing pressure and higher leverage. The company's R&D solutions backlog and pipeline growth indicate sustained demand.

$IQVMed

Learn Why The Bull Case For IQVIA (IQV) Could Change Following AI Trial Platform Launch

IQVIA Holdings priced a $2.0b senior notes offering due 2034 to refinance debt and cover costs. The company launched IQVIA Predictive Clinical Development, an AI-driven platform aimed at accelerating clinical trials. Analysts project revenues of $20.4b and earnings of $2.0b by 2029, but debt remains a key risk. The AI platform could enhance growth and defend pricing power, though competition from in-house pharma tools is a concern.

$IQVHighAI 8/10

IQVIA stock rises amid $2 billion senior notes offering

IQVIA Holdings Inc. (IQV) shares rose 4.3% after announcing a $2 billion senior notes offering due 2034, with a 6.375% interest rate. Proceeds will redeem existing notes, repay debt, and cover offering fees. The offering is expected to close by September 23, 2026, and is targeted at institutional buyers and non-U.S. investors. IQVIA is a global provider of clinical research and healthcare intelligence services.